Vijay Ramanath is a Cardiology physician affiliated with Heart Hospital Baylor Plano. OpenAlex indexes 32 publications with 1,043 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
3 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
79.1%Beta blocker20.4%Carvedilol44%Metoprolol Tartrate27%Metoprolol Succinate25%Nebivolol Hcl2%Atenolol2%Part D<11 patientsStatin16.1%Atorvastatin Calcium72%Rosuvastatin Calcium18%Simvastatin7%Pravastatin Sodium3%Part D<11 patients+ 15 more classes in this area
Blood & clotting
18.9%Factor Xa inhibitor13.5%Eliquis80%Xarelto20%Part D≥88 patientsP2Y12 inhibitor5%Clopidogrel72%Brilinta28%Part D≥50 patients+ 1 more class in this area
Metabolism & gastrointestinal
2%Potassium supplement1.5%Potassium Chloride100%Part D≥19 patientsProton pump inhibitor0.4%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 1-Year Results From the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon
JACC: Cardiovascular Interventions
2021 - Coronary Chronic Total Occlusion Recanalisation – Current Techniques and Approaches
Interventional Cardiology Reviews Research Resources
2013
Similar KOLs
Other experts from the same institution or the same specialty.
Molly Szerlip, MD
Heart Hospital Baylor Plano
Chadi Dib, MD
Heart Hospital Baylor Plano
Sameh Sayfo
Heart Hospital Baylor Plano
Sahil Bakshi, DO
Heart Hospital Baylor Plano
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”